Your session is about to expire
← Back to Search
Behavioral Intervention
Robot + tDCS for Cerebral Palsy (RoboCP Trial)
Phase 2
Waitlist Available
Led By Sean P Dukelow, MD, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
confirmed diagnosis of hemiparetic cerebral palsy due to unilateral perinatal stroke
age 6-18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
Awards & highlights
RoboCP Trial Summary
This trial is testing if adding electrical stimulations to robot-assisted therapy can help improve movement in children with half- paralysis due to cerebral palsy.
Eligible Conditions
- Cerebral Palsy
- Perinatal Stroke
RoboCP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRoboCP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reaching Accuracy
Secondary outcome measures
Assisting Hand Assessment
Box and Block Assessment
Purdue Pegboard
+1 moreRoboCP Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Robot + tDCSExperimental Treatment1 Intervention
10 sessions of 1.5 hrs of robotic therapy within a 3 week period, with 20 minutes of 1mA cathodal tDCS applied to the contralesional M1 area during first 20 minutes of robotic therapy. Robotic therapy will be conducted using the Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
Group II: Robot + sham tDCSPlacebo Group1 Intervention
10 sessions of 1.5 hrs of robotic therapy within a 3 week period with 20 minutes of SHAM tDCS applied during the first 20 minutes of the robotic therapy. As with experimental arm, electrode will be placed on contralesional M1. Current will ramp up and then immediately ramp down to simulate the cutaneous sensations felt with actual tDCS. Robotic therapy will be delivered with Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
780 Previous Clinical Trials
841,714 Total Patients Enrolled
8 Trials studying Cerebral Palsy
302 Patients Enrolled for Cerebral Palsy
Sean P Dukelow, MD, PhDPrincipal InvestigatorUniversity of Calgary
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger